Founder of Alan Boyd Consultants Ltd., Alan Keith Boyd currently holds the position of Chief Executive Officer at Alan Boyd Consultants Ltd. and Director at Baxterboyd Ltd.

He is also on the board of Celentyx Ltd., Spark Therapeutics Ireland Ltd., Clinigen Group Plc and Transine Therapeutics Ltd. and Member of The Royal College of Physicians.

In the past Dr. Boyd occupied the position of Head-Medical Research at Zeneca Pharmaceuticals, Medical Director for Clinigen Group Plc, Principal at Glaxo Group Research Ltd., Director-Research & Development at Ark Therapeutics Group Plc and Director-Clinical & Medical Affairs at AstraZeneca Canada, Inc.

Alan Keith Boyd received an undergraduate degree from the University of Birmingham.